Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia
CA 2348657 C · Owner: Weissenbach, Jean · Inventors: Weissenbach, Jean; Hazan, Jamile
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns the identification and characterisation of the SPG4 gene coding for spastin and some mutations thereof responsible for the most frequent form of autosomal dominant familial spastic paraplegia the cloning and the characterisation of its cDNA and the corresponding polypeptides. The invention also concerns vectors transformed cells and transgenic animals as well as diagnostic methods and kits and methods for selecting a chemical or biological compound capable of directly or indirectly interacting with said polypeptide.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 4, 2000 and granted July 8, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 4, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 4, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.